High incidence of Epstein–Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19
Infectious Diseases Now, ISSN: 2666-9919, Vol: 51, Issue: 3, Page: 296-299
2021
- 130Citations
- 125Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations130
- Citation Indexes130
- 130
- CrossRef1
- Captures125
- Readers125
- 125
- Mentions1
- News Mentions1
- News1
Most Recent News
Risk factors for mortality in kidney transplant recipients with COVID‐19: a single centre experience and case–control study
Devprakash Choudhary ORCID: orcid.org/0000-0002-5804-51431, Deepesh Kenwar ORCID: orcid.org/0000-0002-8357-15081, Ajay Sharma ORCID: orcid.org/0000-0003-4050-65862, Ashish Bhalla ORCID: orcid.org/0000-0001-5210-10123, Sarbpreet Singh ORCID: orcid.org/0000-0002-1072-73051,
Article Description
Systemic reactivation of herpesviruses may occur in intensive care unit (ICU) patients and is associated with morbidity and mortality. Data on severe Coronavirus disease-19 (COVID-19) and concomitant reactivation of herpesviruses are lacking. We selected patients admitted to ICU for confirmed COVID-19 who underwent systematic testing for Epstein–Barr virus (EBV), cytomegalovirus (CMV) and human-herpes virus-6 (HHV-6) DNAemia while in the ICU. We retrospectively analysed frequency, timing, duration and co-occurrence of viral DNAemia. Thirty-four patients were included. Viremia with EBV, CMV, and HHV-6 was detected in 28 (82%), 5 (15%), and 7 (22%) patients, respectively. EBV reactivation occurred early after ICU admission and was associated with longer ICU length-of-stay. While in the ICU, critically ill patients with COVID-19 are prone to develop reactivations due to various types of herpesviruses.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2666991921000051; http://dx.doi.org/10.1016/j.idnow.2021.01.005; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85104356048&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/33495765; https://linkinghub.elsevier.com/retrieve/pii/S2666991921000051; https://dx.doi.org/10.1016/j.idnow.2021.01.005
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know